First Time Loading...

Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 53.64 USD 1.09%
Updated: Mar 29, 2024

Intrinsic Value

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. [ Read More ]

The intrinsic value of one GMED stock under the Base Case scenario is 80.32 USD. Compared to the current market price of 53.64 USD, Globus Medical Inc is Undervalued by 33%.

Key Points:
GMED Intrinsic Value
Base Case
80.32 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Globus Medical Inc

Backtest GMED Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GMED stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Globus Medical Inc's business.

What risks and challenges
does Globus Medical Inc face in the near future?

Summarize the latest earnings report
of Globus Medical Inc.

Provide P/E
for Globus Medical Inc and its competitors.

Financials

Balance Sheet Decomposition
Globus Medical Inc

Current Assets 1.9B
Cash & Short-Term Investments 517.8m
Receivables 504.9m
Other Current Assets 892.7m
Non-Current Assets 3.2B
Long-Term Investments 75.4m
PP&E 647.7m
Intangibles 2.4B
Other Non-Current Assets 88.5m
Current Liabilities 392.3m
Accounts Payable 56.7m
Accrued Liabilities 252m
Other Current Liabilities 83.7m
Non-Current Liabilities 695.8m
Long-Term Debt 417.7m
Other Non-Current Liabilities 278m
Efficiency

Earnings Waterfall
Globus Medical Inc

Revenue
1.6B USD
Cost of Revenue
-548.2m USD
Gross Profit
1B USD
Operating Expenses
-818.5m USD
Operating Income
201.9m USD
Other Expenses
-79m USD
Net Income
122.9m USD

Free Cash Flow Analysis
Globus Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GMED Profitability Score
Profitability Due Diligence

Globus Medical Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
61/100
Profitability
Score

Globus Medical Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

GMED Solvency Score
Solvency Due Diligence

Globus Medical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Globus Medical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMED Price Targets Summary
Globus Medical Inc

Wall Street analysts forecast GMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMED is 62.81 USD with a low forecast of 25.25 USD and a high forecast of 87.15 USD.

Lowest
Price Target
25.25 USD
53% Downside
Average
Price Target
62.81 USD
17% Upside
Highest
Price Target
87.15 USD
62% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

GMED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

GMED Price
Globus Medical Inc

1M 1M
-1%
6M 6M
+8%
1Y 1Y
+0%
3Y 3Y
-11%
5Y 5Y
+9%
10Y 10Y
+102%
Annual Price Range
53.64
52w Low
43.79
52w High
62.37
Price Metrics
Average Annual Return 10.64%
Standard Deviation of Annual Returns 9.74%
Max Drawdown -48%
Shares Statistics
Market Capitalization 7.3B USD
Shares Outstanding 135 370 000
Percentage of Shares Shorted 5.12%

GMED Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Globus Medical Inc Logo
Globus Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

7.3B USD

Dividend Yield

0%

Description

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2012-03-08. The company is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. The company groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. The company offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screw and rod systems.

Contact

PENNSYLVANIA
Audubon
2560 General Armistead Ave
+16109301800.0
http://www.globusmedical.com/

IPO

2012-03-08

Employees

2 400

Officers

Co-Founder & Executive Chairman
Mr. David C. Paul
President, CEO & Director
Mr. Daniel T. Scavilla
CFO & COO
Mr. Keith W. Pfeil
Senior VP, General Counsel & Secretary
Ms. Kelly G. Huller Esq.
Senior Vice President of Business Development & Investor Relations
Mr. Brian J. Kearns

See Also

Discover More
What is the Intrinsic Value of one GMED stock?

The intrinsic value of one GMED stock under the Base Case scenario is 80.32 USD.

Is GMED stock undervalued or overvalued?

Compared to the current market price of 53.64 USD, Globus Medical Inc is Undervalued by 33%.